These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33358985)

  • 1. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
    Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
    Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
    de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
    Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
    Schultz S; Gould GG; Antonucci N; Brigida AL; Siniscalco D
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.
    Schiavi S; Manduca A; Carbone E; Buzzelli V; Rava A; Feo A; Ascone F; Morena M; Campolongo P; Hill MN; Trezza V
    Neuropsychopharmacology; 2023 May; 48(6):897-907. PubMed ID: 36114286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of cannabinoids as treatments for autism spectrum disorders.
    Nezgovorova V; Ferretti CJ; Taylor BP; Shanahan E; Uzunova G; Hong K; Devinsky O; Hollander E
    J Psychiatr Res; 2021 May; 137():194-201. PubMed ID: 33689997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid treatment for autism: a proof-of-concept randomized trial.
    Aran A; Harel M; Cassuto H; Polyansky L; Schnapp A; Wattad N; Shmueli D; Golan D; Castellanos FX
    Mol Autism; 2021 Feb; 12(1):6. PubMed ID: 33536055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.
    Fyke W; Alarcon JM; Velinov M; Chadman KK
    Autism Res; 2021 Jul; 14(7):1375-1389. PubMed ID: 33886158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower circulating endocannabinoid levels in children with autism spectrum disorder.
    Aran A; Eylon M; Harel M; Polianski L; Nemirovski A; Tepper S; Schnapp A; Cassuto H; Wattad N; Tam J
    Mol Autism; 2019; 10():2. PubMed ID: 30728928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies.
    De Pol M; Kolla NJ
    Psychiatry Res; 2021 Dec; 306():114256. PubMed ID: 34775294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models.
    Pietropaolo S; Marsicano G
    Neurosci Biobehav Rev; 2022 Jan; 132():664-678. PubMed ID: 34813825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
    Pedrazzi JFC; Ferreira FR; Silva-Amaral D; Lima DA; Hallak JEC; Zuardi AW; Del-Bel EA; Guimarães FS; Costa KCM; Campos AC; Crippa ACS; Crippa JAS
    Psychopharmacology (Berl); 2022 Sep; 239(9):2713-2734. PubMed ID: 35904579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats.
    Zamberletti E; Gabaglio M; Woolley-Roberts M; Bingham S; Rubino T; Parolaro D
    Front Cell Neurosci; 2019; 13():367. PubMed ID: 31447649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cannabinoids in neurodevelopmental disorders of children and adolescents.
    Dias-de Freitas F; Pimenta S; Soares S; Gonzaga D; Vaz-Matos I; Prior C
    Rev Neurol; 2022 Oct; 75(7):189-197. PubMed ID: 36169325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dopamine Hypothesis of Autism Spectrum Disorder.
    Pavăl D
    Dev Neurosci; 2017; 39(5):355-360. PubMed ID: 28750400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid Signaling in Autism.
    Chakrabarti B; Persico A; Battista N; Maccarrone M
    Neurotherapeutics; 2015 Oct; 12(4):837-47. PubMed ID: 26216231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Endocannabinoid System: Exploring Its Therapeutic Potential in Autism Spectrum Disorder.
    Jana A; Nath A; Sen P; Kundu S; Alghamdi BS; Abujamel TS; Saboor M; Woon-Khiong C; Alexiou A; Papadakis M; Alam MZ; Ashraf GM
    Neuromolecular Med; 2024 May; 26(1):20. PubMed ID: 38744725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the endocannabinoid system in neurological disorders.
    Zou M; Li D; Li L; Wu L; Sun C
    Int J Dev Neurosci; 2019 Aug; 76():95-102. PubMed ID: 30858029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammatory Gene Expression Alterations in Anterior Cingulate Cortical White and Gray Matter of Males With Autism Spectrum Disorder.
    Sciara AN; Beasley B; Crawford JD; Anderson EP; Carrasco T; Zheng S; Ordway GA; Chandley MJ
    Autism Res; 2020 Jun; 13(6):870-884. PubMed ID: 32129578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the endocannabinoid system in autism spectrum disorders: Evidence from mouse studies.
    Pietropaolo S; Bellocchio L; Bouzón-Arnáiz I; Yee BK
    Prog Mol Biol Transl Sci; 2020; 173():183-208. PubMed ID: 32711810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism.
    Araujo DJ; Tjoa K; Saijo K
    Front Cell Neurosci; 2019; 13():424. PubMed ID: 31619967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.